536 results on '"Höglund, Martin"'
Search Results
2. The impact of Covid-19 in patients with chronic myeloid leukemia—a nationwide population-based study
3. Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
4. Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis
5. Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data
6. Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
7. Epidemiology of Chronic Myeloid Leukaemia
8. Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression
9. Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial
10. Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets
11. Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study
12. Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
13. P506: CLINICAL VALIDATION OF THE NORDIC GUIDELINES FOR GERMLINE TESTING IN MYELOID NEOPLASMS: RESULTS FROM A MULTI-CENTER PROSPECTIVE COHORT STUDY
14. P513: MOLECULAR PATTERN BY AGE AND OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA: A POPULATION-BASED STUDY FROM THE SWEDISH AML REGISTRY.
15. S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS
16. The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
17. Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting
18. Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry
19. Transparent Wood Biocomposite of Well-Dispersed Dye Content for Fluorescence and Lasing Applications
20. Towards repositioning of quinacrine for treatment of acute myeloid leukemia – Promising synergies and in vivo effects
21. Supplementary Figures 1 through 3 from The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses
22. Data from The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses
23. Figure S2 from A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
24. Table S1 from A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
25. Epidemiology of Chronic Myeloid Leukemia
26. Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics
27. Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
28. Noninvasive detection of any-stage cancer using free glycosaminoglycans
29. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
30. Characterization of therapy-related acute myeloid leukemia : increasing incidence and prognostic implications
31. IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
32. Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications
33. Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial
34. Cardiovascular disease in patients with chronic lymphocytic leukemia: A Swedish nationwide register study with matched comparators
35. A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
36. Visual and performance comparison: Physically based atmosphere method against Unity Universal Render Pipeline procedural skybox
37. A risk score based on real-world data to predict early death in acute promyelocytic leukemia
38. A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
39. Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era – a report from the Swedish CML register
40. Epidemiology of chronic myeloid leukaemia: an update
41. Acute myeloid leukemia in the real world: why population-based registries are needed
42. Charge Regulated Diffusion of Silica Nanoparticles into Wood for Flame Retardant Transparent Wood
43. A risk score based on real-world data to predict early death in acute promyelocytic leukemia
44. Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study
45. Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden
46. Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia
47. The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing
48. Impact of treatment delay in acute myeloid leukemia revisited
49. Socioeconomic cost of AML in Sweden—A population‐based study using multiple nation‐wide registers
50. Facile Processing of Transparent Wood Nanocomposites with Structural Color from Plasmonic Nanoparticles
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.